Canada markets open in 3 hours 26 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
13.03+0.65 (+5.25%)
At close: 04:00PM EDT
13.12 +0.09 (+0.69%)
After hours: 07:29PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close12.38
Open12.38
Bid12.99 x 100
Ask13.03 x 100
Day's Range12.34 - 13.13
52 Week Range3.84 - 13.32
Volume291,785
Avg. Volume543,224
Market Cap304.516M
Beta (5Y Monthly)1.05
PE Ratio (TTM)N/A
EPS (TTM)-6.09
Earnings DateMay 08, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.25
  • PR Newswire

    INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine

    INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO will participate in The Novel Therapeutics Forum hosted by Citizens JMP at Penn Medicine at 10:00 am ET on April 2, 2024.

  • Zacks

    Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?

    The consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

  • Insider Monkey

    Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript

    Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript March 6, 2024 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.12, expectations were $-1.58. Inovio Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]